Cargando…
An Amphotericin B Derivative Equally Potent to Amphotericin B and with Increased Safety
Amphotericin B is the most potent antimycotic known to date. However due to its large collateral toxicity, its use, although long standing, had been limited. Many attempts have been made to produce derivatives with reduced collateral damage. The molecular mechanism of polyene has also been closely s...
Autores principales: | Antillón, Armando, de Vries, Alexander H., Espinosa-Caballero, Marcel, Falcón-González, José Marcos, Flores Romero, David, González–Damián, Javier, Jiménez-Montejo, Fabiola Eloísa, León-Buitimea, Angel, López-Ortiz, Manuel, Magaña, Ricardo, Marrink, Siewert J., Morales-Nava, Rosmarbel, Periole, Xavier, Reyes-Esparza, Jorge, Rodríguez Lozada, Josué, Santiago-Angelino, Tania Minerva, Vargas González, María Cristina, Regla, Ignacio, Carrillo-Tripp, Mauricio, Fernández-Zertuche, Mario, Rodríguez-Fragoso, Lourdes, Ortega-Blake, Iván |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040443/ https://www.ncbi.nlm.nih.gov/pubmed/27683101 http://dx.doi.org/10.1371/journal.pone.0162171 |
Ejemplares similares
-
Encochleated Amphotericin B: Is the Oral Availability of Amphotericin B Finally Reached?
por: Aigner, Maria, et al.
Publicado: (2020) -
Amphotericin-B in Dermatology
por: Agarwal, Akash, et al.
Publicado: (2022) -
Amphotericin-B/amphotericin-B-liposomal: Lack of efficacy: 2 case reports
Publicado: (2022) -
Protective and antifungal properties of Nanodisk-Amphotericin B over commercially available Amphotericin B()
por: Cho, Do-Yeon, et al.
Publicado: (2017) -
Liposomal amphotericin B—the present
por: Maertens, J, et al.
Publicado: (2022)